tetano
Editor, Senior Moderator
Expert Opin Biol Ther. 2020 May 14. doi: 10.1080/14712598.2020.1770222. [Epub ahead of print]
Tocilizumab: From the Rheumatology Practice to the Fight Against COVID-19, a virus infection with multiple faces.
Gonz?lez-Gay MA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Mayo J[SUP]4[/SUP], Casta?eda S[SUP]5[/SUP], Cifri?n JM[SUP]6[/SUP], Hern?ndez-Rodr?guez J[SUP]7[/SUP].
Author information
KEYWORDS:
COVID-19; anakinra; chimeric antigen receptor (CAR) T cell‐induced cytokine release syndrome; colchicine; coronavirus; inflammation; interleukin-6; macrophage activation syndrome; tocilizumab
PMID:32406282DOI:10.1080/14712598.2020.1770222
Tocilizumab: From the Rheumatology Practice to the Fight Against COVID-19, a virus infection with multiple faces.
Gonz?lez-Gay MA[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Mayo J[SUP]4[/SUP], Casta?eda S[SUP]5[/SUP], Cifri?n JM[SUP]6[/SUP], Hern?ndez-Rodr?guez J[SUP]7[/SUP].
Author information
KEYWORDS:
COVID-19; anakinra; chimeric antigen receptor (CAR) T cell‐induced cytokine release syndrome; colchicine; coronavirus; inflammation; interleukin-6; macrophage activation syndrome; tocilizumab
PMID:32406282DOI:10.1080/14712598.2020.1770222